What is the current Price Target for the Nautilus Biotechnology stock?

The average Nautilus Biotechnology target price is $1.88. This is 169.24% higher than the current stock price. The highest price target is 330.79%, the lowest is 43.60%. 4 Analysts have issued a price target Nautilus Biotechnology 2026 .

How high will the Nautilus Biotechnology stock rise?

No reliable answer can be given as to how high the Nautilus Biotechnology stock will rise. The performance of stocks, including the Nautilus Biotechnology stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Nautilus Biotechnology stock today?

The performance of Nautilus Biotechnology stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Nautilus Biotechnology stock fall?

The decline in Nautilus Biotechnology stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Nautilus Biotechnology Forecast, price target & analysts

$0.70

7.27% yesterday

Nasdaq, Apr 04, 10:00 pm CET

ISIN

US63909J1088

Symbol

NAUT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Nautilus Biotechnology Target price 2025 - Analyst rating & recommendation

Nautilus Biotechnology Classifications & Recommendation:

Buy

40%

Hold

40%

Sell

20%

Nautilus Biotechnology Price Target

Target Price	$1.88
Price	$0.70
Potential	169.24% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Nautilus Biotechnology 2026 . The average Nautilus Biotechnology target price is $1.88. This is 169.24% register free of charge higher than the current stock price. The highest price target is $3.00 330.79% register free of charge , the lowest is $1.00 43.60% register free of charge .
	A rating was issued by 5 analysts: 2 Analysts recommend Nautilus Biotechnology to buy, 2 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Nautilus Biotechnology stock has an average upside potential 2026 of 169.24% register free of charge . Most analysts recommend the Nautilus Biotechnology stock at Buy or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.56	-0.57
	9.80%	1.79%
P/E		negative

1 Analysts have issued a Nautilus Biotechnology forecast for earnings per share. The average Nautilus Biotechnology EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.56	9.80%
2025	$-0.57 1.79% Unlock
2026	$-0.63 10.53% Unlock
2027	$-0.68 7.94% Unlock
2028	$-0.68 0.00% Unlock
2029	$-0.64 5.88% Unlock

Current	-1.23	78.65%
2025	-1.22 0.81% Unlock
2026	-1.11 9.02% Unlock
2027	-1.02 8.11% Unlock
2028	-1.02 0.00% Unlock
2029	-1.09 6.86% Unlock

Nautilus Biotechnology...

Current Nautilus Biotechnology Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Goldman Sachs	Locked ➜ Locked	Locked	Dec 05 2024

Analyst Rating	Date
Locked Goldman Sachs: Locked ➜ Locked	Dec 05 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 95.20%

BioNTech SE - ADR 57.25%

Amazon.com 55.96%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now